| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |